Investor Relations
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jun 5, 2018Proof of concept study successful in demonstrating potential SNP multiplexing applications
-
Jun 1, 2018CoPrimers™ used in proof of concept evaluation
-
Apr 6, 2018CODX updates on initial six months as a public company
-
Mar 22, 2018Project moving forward on schedule, with production to begin in Q3 2018
-
Feb 21, 2018Shipment includes 10,000 tests to be sold as Research Use Only by Joint Venture
-
Jan 30, 2018Program received enthusiastically by regional Ministries of Health
-
Dec 19, 2017Laboratory will meet CGMP Requirements of FDA; Will be BSL-2 to allow enhanced in-house verification and validation activities
-
Aug 24, 2017Sales expected upon successful performance evaluation and validation
-
Aug 21, 2017
-
Aug 10, 2017Audit to prepare for eventual sales into the US market
-
Aug 2, 2017
-
Jul 27, 2017